Grit Bio

沙砾生物GRIT Biotechnology是一家聚焦世界尖端生物科技,专注于肿瘤免疫治疗领域的高科技创新企业。

China · Founded 2019 · $75.3M raised

Founded
2019
Total Funding
$75.3M
Last Round
$60.0M Series BSep 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Grit Bio focuses on the research, development, and industrialization of next-generation T-cell therapies. It is building a diverse T-cell product portfolio spanning personalized therapies, enhanced cell-therapy function, allogeneic approaches, and in-vivo programming, covering multiple technology paths and treatment settings.

Summary

Grit Bio is a Biotech company based in China, founded in 2019. It has raised $75.3M in total across 3 rounds, most recently a $60.0M Series B round in Sep 2023. Investors include GL Ventures, CICC and Qianhai Ark.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2023
$60.0M

Sign up to see all 3 events

Funding: Extension Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Grit Bio on Indexed.vc
<a href="https://indexed.vc/companies/grit-bio"><img src="https://indexed.vc/api/badge/company/grit-bio" alt="Grit Bio on Indexed.vc" width="260" height="76" /></a>